Key result
LACI enhances cardiovascular risk stratification by integrating atrial and ventricular dynamics.
Why the study?
Traditional cardiac function assessments have long-standing limitations that the left atrioventricular coupling index may address by integrating atrial and ventricular dynamics.
LACI provides a comprehensive perspective on cardiac health by integrating atrial and ventricular dynamics, serving as a promising imaging biomarker for risk stratification and diagnostics in cardiovascular medicine.
The left atrioventricular coupling index (LACI) has emerged as a novel and transformative biomarker in cardiovascular research, addressing long-standing limitations in traditional cardiac function assessments. By quantifying the ratio of left atrial to left ventricular end-diastolic volumes, LACI offers unprecedented prognostic insights into a wide range of cardiovascular diseases, including atrial fibrillation, heart failure, and myocardial infarction, as well as other conditions such as hypertension and cardiomyopathies. Recent evidence highlights its unique ability to integrate atrial and ventricular dynamics, offering a more comprehensive perspective on cardiac health and disease progression. This review synthesizes the latest advancements in LACI research, elucidates its underlying pathophysiological mechanisms, and explores its expanding clinical applications as a pivotal tool for risk stratification, precision diagnostics, and personalized therapy in cardiovascular medicine.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) conducted a review in Cardiovascular disease. Left atrioventricular coupling index (LACI) was evaluated. The left atrioventricular coupling index (LACI) has emerged as a transformative prognostic biomarker that integrates atrial and ventricular dynamics to enhance risk stratification across cardiovascular diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: